3rdPartyFeeds

Will Weak Express Unit Hurt FedEx's (FDX) Earnings in Q1?

The first-quarter fiscal 2020 results of FedEx's (FDX) largest revenue-generating unit are likely to be hurt by a drop in revenues from international priority packages. Read More...

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="FedEx Corporation’s FDX Express segment, which accounts for more than 50% of the company’s total revenues and around 48% of its operating income, is expected to report dismal first-quarter fiscal 2020 results (ended Aug 31, 2019). This, in turn, might hurt FedEx’s quarterly outperformance when it reports on Sep 17. (See more in FedEx to Report Q1 Earnings: What’s in the Offing?)&nbsp; &nbsp;” data-reactid=”18″>FedEx Corporation’s FDX Express segment, which accounts for more than 50% of the company’s total revenues and around 48% of its operating income, is expected to report dismal first-quarter fiscal 2020 results (ended Aug 31, 2019). This, in turn, might hurt FedEx’s quarterly outperformance when it reports on Sep 17. (See more in FedEx to Report Q1 Earnings: What’s in the Offing?)   

FedEx Express offers time-definite delivery to more than 220 countries and territories, connecting markets that comprise almost the entire gross domestic product of the world. Additionally, the segment employs approximately 227,000 employees and has approximately 100,000 drop-off locations (including FedEx Office stores and FedEx OnSite locations), 670 aircraft and approximately 90,000 vehicles across the globe.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="FedEx Express’ Q4 Performance” data-reactid=”20″>FedEx Express’ Q4 Performance

Quarterly revenues at FedEx Express (including TNT Express) dropped 1% year over year to $9.5 billion. Operating income came in at $766 million, down 12% year over year. Also, operating margin contracted to 8.1% from 9% in the year-ago quarter.

Notably, the unit witnessed a 5% decrease in revenues from international priority packages. Results were hurt by the weakness in global trade and industrial production. Freight revenues at the segment declined 7% to $1,852 million. The sluggish freight scenario in the United States partly contributed to the gloomy picture.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Weakness in FedEx Express Likely to Persist in Q1” data-reactid=”23″>Weakness in FedEx Express Likely to Persist in Q1

As the trade dispute between the two largest economies in the world – the United States and China – is not yet resolved, results of FedEx’s largest revenue-generating segment are likely to be hurt in the soon-to-be reported quarter. A slowdown in global trade and lackluster freight scenario in the United States may also weigh on the segment’s results.

FedEx’s decision not to renew a shipping contract between its Express division and e-commerce giant Amazon AMZN may also drag down the segment’s first-quarter results.

Reflecting the above headwinds, the Zacks Consensus Estimate for first-quarter revenues at the FedEx Express unit stands at $8,868 million. In the year-ago quarter, the segment recorded revenues of $9,222 million.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Overall Earnings &amp; Revenue Projections” data-reactid=”27″>Overall Earnings & Revenue Projections

For FedEx, which competes with United Parcel Service UPS in the package delivery space, the Zacks Consensus Estimate for first-quarter earnings is pegged at $3.20, indicating a 7.5% decline from the prior-year quarter’s $3.46 per share. For quarterly sales, the consensus mark of $17.14 billion suggests a marginal increase on a year-over-year basis.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Our Take” data-reactid=”29″>Our Take

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Factors like the ongoing trade uncertainty and sluggish industrial production are likely to hamper FedEx Express results in the quarter to be reported. This, in turn, will weigh on this Zacks Rank #3 (Hold) company’s top and bottom lines. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.” data-reactid=”30″>Factors like the ongoing trade uncertainty and sluggish industrial production are likely to hamper FedEx Express results in the quarter to be reported. This, in turn, will weigh on this Zacks Rank #3 (Hold) company’s top and bottom lines. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Key Pick” data-reactid=”31″>Key Pick

Investors interested in the Zacks Transportation sector may consider GATX Corporation GATX sporting a Zacks Rank #1. Shares of GATX have gained more than 13% so far this year.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now&gt;&gt;” data-reactid=”33″>Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
&nbsp;
GATX Corporation (GATX) : Free Stock Analysis Report
&nbsp;
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
&nbsp;
United Parcel Service, Inc. (UPS) : Free Stock Analysis Report
&nbsp;
FedEx Corporation (FDX) : Free Stock Analysis Report
&nbsp;
To read this article on Zacks.com click here.” data-reactid=”34″>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
GATX Corporation (GATX) : Free Stock Analysis Report
 
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
 
United Parcel Service, Inc. (UPS) : Free Stock Analysis Report
 
FedEx Corporation (FDX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Read More

Add Comment

Click here to post a comment